Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

Background: Dyspnea is a common, distressing symptom of cardiopulmonary and
neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in …

COPD is a progressive condition involving chronic inflammation and parenchymal
destruction with resulting airflow limitation. COPD is associated with worsening airflow …

Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP
on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was …

Lung function in chronic obstructive pulmonary disease (COPD) can be improved acutely by
oral corticosteroids and bronchodilators. Whether clinical improvement can be maintained …

Background The peripheral blood eosinophil count might help identify those patients with
chronic obstructive pulmonary disease (COPD) who will experience fewer exacerbations …

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and
improve health status in chronic obstructive pulmonary disease (COPD). However, their …

Partial bronchodilator reversibility can be demonstrated in many patients with stable chronic
obstructive pulmonary disease (COPD), but its relevance to exercise capacity and symptoms …

BACKGROUND--An association between asthma and gastro-oesophageal reflux is well
recognised but the underlying mechanism is unclear. One suggestion is that gastric juice is …